drugset / Trial / NCT00688961

Effects of Omacor and Aspirin on Platelet Function

NCT00688961

Phase 0 Completed 10 enrolled Sanford Research
Non-randomizedFactorialOpen-labelTreatment

Summary

Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can affect blood clotting by altering the function of the blood platelets. Aspirin can do the same. The purpose of this study is to determine the individual and combined effects of these two agents on platelet function using a whole blood method.

Timeline

Start
2007-06
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 625 mg
Subject Lovaza Other / unclassified 4 g

Indications

No indication recorded.